MAST4 and Alzheimer disease: AICD binding to the MAST4 promoter was lower in late-onset AD brains compared to control cases (no neurologic disease) and FTD brains (Fig. 6A), which was accompanied by less MAST4 mRNA and protein abundance (Fig. 6B–D).